Department of Medicine, University of British Columbia, Vancouver, BC, Canada.
Department of Medicine, University of Calgary, Calgary, AB, Canada.
Lancet. 2017 Oct 21;390(10105):1888-1917. doi: 10.1016/S0140-6736(17)30788-2. Epub 2017 Apr 20.
The global nephrology community recognises the need for a cohesive plan to address the problem of chronic kidney disease (CKD). In July, 2016, the International Society of Nephrology hosted a CKD summit of more than 85 people with diverse expertise and professional backgrounds from around the globe. The purpose was to identify and prioritise key activities for the next 5-10 years in the domains of clinical care, research, and advocacy and to create an action plan and performance framework based on ten themes: strengthen CKD surveillance; tackle major risk factors for CKD; reduce acute kidney injury-a special risk factor for CKD; enhance understanding of the genetic causes of CKD; establish better diagnostic methods in CKD; improve understanding of the natural course of CKD; assess and implement established treatment options in patients with CKD; improve management of symptoms and complications of CKD; develop novel therapeutic interventions to slow CKD progression and reduce CKD complications; and increase the quantity and quality of clinical trials in CKD. Each group produced a prioritised list of goals, activities, and a set of key deliverable objectives for each of the themes. The intended users of this action plan are clinicians, patients, scientists, industry partners, governments, and advocacy organisations. Implementation of this integrated comprehensive plan will benefit people who are at risk for or affected by CKD worldwide.
全球肾脏病学领域的专业人士认识到,需要制定一个协调一致的计划来解决慢性肾脏病(CKD)的问题。2016 年 7 月,国际肾脏病学会举办了一次 CKD 峰会,来自全球的 85 多名专家参加了这次峰会,他们具有不同的专业知识和背景。本次峰会旨在确定并确定未来 5-10 年在临床护理、研究和宣传领域的重点活动,并根据十个主题制定行动计划和绩效框架:加强 CKD 监测;解决 CKD 的主要危险因素;减少急性肾损伤——CKD 的一个特殊危险因素;增强对 CKD 遗传原因的了解;建立更好的 CKD 诊断方法;提高对 CKD 自然病程的认识;评估和实施 CKD 患者的既定治疗方案;改善 CKD 症状和并发症的管理;开发减缓 CKD 进展和减少 CKD 并发症的新治疗干预措施;并增加 CKD 临床试验的数量和质量。每个小组都为每个主题的目标、活动和一系列关键可交付成果制定了优先清单。该行动计划的预期使用者是临床医生、患者、科学家、行业合作伙伴、政府和宣传组织。实施这一综合全面计划将使全球范围内有 CKD 风险或受 CKD 影响的人群受益。